Mitochondrial Complexes and ATP Synthase

Mitochondrial Complexes Overview
  • Understanding the crucial role of mitochondrial complexes in cellular respiration, specifically in oxidative phosphorylation, which integrates the electron transport chain (ETC) and ATP synthesis.

  • These complexes are integral to generating a proton gradient across the inner mitochondrial membrane, driving the synthesis of the vast majority of cellular ATP.

General Structure of Mitochondria
  • Mitochondria consist of various specialized compartments, each with distinct functions:

    • OMM (Outer Mitochondrial Membrane)

      • Highly permeable due to the presence of porins, allowing passage of small molecules and ions.

    • IMS (Intermembrane Space)

      • The space between the OMM and IMM. Protons are pumped into this space, creating the proton gradient essential for ATP synthesis.

    • IMM (Inner Mitochondrial Membrane)

      • Highly impermeable and selectively permeable, folded into cristae to increase surface area.

      • It is the site of the electron transport chain complexes (Complexes I-IV) and ATP synthase.

Complex I (NADH: Ubiquinone Oxidoreductase)
  • Structure and Function:

    • Complex I is a large, L-shaped multi-subunit enzyme embedded in the IMM.

    • It catalyzes the transfer of electrons from NADH (produced in the Krebs cycle and glycolysis) to Ubiquinone (UQ).

    • Reaction: NADH+H+→NAD++2e−+2H+NADH+H+→NAD++2e−+2H+.

    • These electrons are initially transferred to FMN (Flavin Mononucleotide), forming FMNH2FMNH2​ (the reduced form of FMN).

    • From FMNH2FMNH2​, electrons are passed through a series of iron-sulfur (Fe-S) clusters within the complex, utilizing changes in redox potential to facilitate electron transfer.

    • The electrons ultimately reduce UQ (Ubiquinone), a lipid-soluble carrier, to UQH2UQH2​ (Ubiquinol).

    • This entire reduction sequence, driven by the energy released from electron transfer, enables Complex I to pump 4 protons (H++) from the mitochondrial matrix into the Intermembrane Space (IMS) per NADH oxidized. This proton pumping contributes significantly to the proton-motive force.

Summary of Step by Step Process:

  • Reaction at the matrix side:

    • NADH+H+→NAD++2e−+2H+NADH+H+→NAD++2e−+2H+

  • Electrons flow through FMN and multiple iron-sulfur clusters to UQ:

    • UQ+2e−+2H+→UQH2UQ+2e−+2H+→UQH2​

Complex II (Succinate Dehydrogenase)
  • Converts Succinate to Fumarate as part of the Krebs cycle (TCA cycle).

  • It is unique because it is the only enzyme that participates in both the TCA cycle and the ETC, directly linking the two pathways.

  • Processes FAD (bound as a prosthetic group) to FADH2FADH2​, and sends the resulting electrons directly to Ubiquinone (UQ), effectively adding to the pool of electron carriers from a different entry point than Complex I.

  • Crucially, Complex II does not span the inner mitochondrial membrane and therefore does not pump protons into the IMS. Its primary role is to feed electrons from succinate oxidation into the Q pool.

Summary:

  • Succinate+FAD→Fumarate+FADH2Succinate+FADFumarate+FADH2​

  • FADH2FADH2 then transfers electrons to UQ, forming UQH2UQH2.

  • No protons are pumped from Complex II.

Complex III (Ubiquinol-cytochrome c reductase)
  • Also known as the cytochrome bc1 complex, it is a key component of the ETC and catalyzes the transfer of electrons from UQH2UQH2​ to cytochrome c.

  • Steps include the Q-cycle, a sophisticated mechanism that results in the pumping of protons:

    • UQH2UQH2 binds at the QPQP site (positive side, near IMS), releasing its two electrons and two protons into the IMS.

    • One electron is transferred to cytochrome c1c1​ and then to cytochrome c (a peripheral protein in the IMS).

    • The second electron is transferred to cytochrome b, then to another UQ molecule at the QNQN site (negative side, near matrix), reducing it to a semiquinone radical (UQ−UQ).

    • A second molecule of UQH2UQH2 goes through a similar process, releasing two more protons into the IMS, and providing a second electron to reduce the UQ−UQ at the QNQN site, along with two protons from the matrix, to form a full UQH2UQH2​ molecule.

    • This cyclic electron transfer results in the release of 4 protons into the IMS for every 2 electrons passed to cytochrome c (effectively, for every UQH2UQH2 oxidized and a new UQH2UQH2 regenerated).

Complex IV (Cytochrome c oxidase)
  • Receives electrons from the reduced cytochrome c (which carries one electron at a time from Complex III).

  • Complex IV contains four redox-active metal centers: two heme irons (heme aa and heme a3a3) and two copper centers (CuACuA and CuBCuB).

  • Steps involved:

    • Cytochrome c (reduced) transfers electrons one by one to the copper and heme centers within Complex IV, becoming Cytochrome c (oxidized).

    • These electrons are ultimately passed to molecular oxygen (O2O2​), which acts as the terminal electron acceptor.

    • Process: 4e−+O2+4H+→2H2O4e−+O2+4H+→2H2O.

    • This reduction of oxygen consumes 4 protons from the matrix to form water.

  • Result of Complex IV:

    • In addition to consuming protons from the matrix to form water, Complex IV also pumps 2-4 protons (typically 4 protons are reported in many textbooks) from the matrix into the IMS for every molecule of O2O2​ reduced.

    • This significant movement of protons into the IMS further contributes to the proton gradient needed for ATP synthesis.

Proton Gradient and ATP Synthase
  • The cumulative action of Complexes I, III, and IV establishes a substantial proton gradient (electrochemical potential), also known as the Proton-Motive Force (ΔpΔp), across the IMM.

  • ATP Synthase (Complex V) harnesses this force to synthesize ATP.

  • ATP Synthase Structure:

    • Composed of two main subunits:

      • F0F0​ subunit: A hydrophobic, transmembrane component embedded in the IMM. It forms a proton channel and contains a rotating c-ring that responds to proton flow.

      • F1F1 subunit: A hydrophilic, catalytic component that projects into the mitochondrial matrix. It is responsible for the actual synthesis of ATP from ADP and PiPi.

  • Mechanism:

    • Protons flow from the high concentration in the IMS, through the F0F0​ portion into the matrix.

    • This proton flow drives the rotation of the c-ring within the F0F0 subunit, which in turn causes conformational changes in the F1F1 part through a rotating stalk.

    • The conformational changes in the F1F1 subunit allow it to bind ADP and PiPi, catalyze their condensation into ATP, and then release the newly synthesized ATP (the binding change mechanism).

    • Resultantly, approximately 3.7 protons are required to flow through ATP synthase for the synthesis and release of 1 ATP molecule (including the cost of transporting ADP/ATP and PiPi).

ATP Yield Calculation

These calculations represent theoretical maximum yields and can vary in vivo due to factors like proton leakage and shuttle systems.

From NADH:

  1. One NADH molecule's electrons passing through the ETC produces roughly 10 protons pumped:

    • 4 protons (from Complex I) + 4 protons (from Complex III) + 2 protons (from Complex IV) = 10 protons.

  2. ATP yield from NADH = 10 protons/3.7 protons/ATP≈2.7 ATP10 protons/3.7 protons/ATP≈2.7 ATP.

From FADH2FADH2​:

  1. FADH2FADH2​ electrons enter the ETC at Complex II (not pumping protons), but subsequently cause protons to be pumped by Complex III and Complex IV. This correlates with 6 protons pumped downstream:

    • 4 protons (from Complex III via the Q-cycle) + 2 protons (from Complex IV) = 6 protons.

  2. ATP yield from FADH2FADH2​ = 6 protons/3.7 protons/ATP≈1.6 ATP6 protons/3.7 protons/ATP≈1.6 ATP.

Summary Efficiency:

  • Typical yield from aerobic respiration: The full oxidation of one glucose molecule yields approximately 30 to 32 ATP molecules.

    • This includes 2 ATP from glycolysis, 2 ATP from the TCA cycle (as GTP, equivalent to ATP), and the majority (26-28 ATP) from oxidative phosphorylation (combined ATP from NADH and FADH2FADH2​).

    • For instance, if considering 10 NADH (2 from glycolysis, 2 from pyruvate oxidation, 6 from TCA) and 2 FADH2FADH2​ (from TCA), this would be approximately (10×2.7)+(2×1.6)=27+3.2=30.2 ATP(10×2.7)+(2×1.6)=27+3.2=30.2 ATP. Added to 4 substrate-level ATP, this gives 34.2 ATP34.2 ATP.

  • Efficiency calculated for oxidative phosphorylation:

    • Efficiency = (Energy stored in ATP / Total metabolizable energy from glucose oxidation) ×× 100.

    • Resulting in approximately 58% to 60% efficiency of ATP production under optimal conditions, making cellular respiration remarkably efficient compared to man-made machines.

Inhibitors of Mitochondrial Complexes
  • Specific inhibitors can severely impact complex functionality, leading to disruption of the proton gradient and ATP synthesis:

    • Complex I Inhibitors:

      • Rotenone: A potent pesticide and piscicide that binds to Complex I and prevents the transfer of electrons from the iron-sulfur clusters to ubiquinone, thereby blocking the entire ETC.

      • MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine): A neurotoxin that is metabolized to MPP+, which specifically inhibits Complex I in the substantia nigra. This impacts neuronal activity, leading to symptoms resembling Parkinson's disease (e.g., the "living statue effect").

    • Complex II Inhibitors:

      • Malonate: A competitive inhibitor of succinate dehydrogenase (Complex II).

      • Carboxin: A fungicide that targets Complex II.

    • Complex III Inhibitors:

      • Antimycin A: Blocks electron transfer from cytochrome b to cytochrome c1c1​ in Complex III, thus stopping the Q-cycle.

    • Complex IV Inhibitors:

      • Cyanide (CN−CN), Carbon Monoxide (CO), Azide (N3−N3−): These toxic substances bind very tightly to the ferric iron (Fe3+)Fe3+) in the heme groups of cytochrome a3a3 in Complex IV, preventing the final transfer of electrons to oxygen and completely halting the ETC.

    • ATP Synthase Inhibitors:

      • Oligomycin: Directly binds to the F0F0​ subunit of ATP synthase, blocking the proton channel and preventing proton flow, thereby inhibiting ATP synthesis.